Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial

Published:2015-05 Issue:5 Volume:16 Page:531-540
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Blay Jean-Yves,Pápai Zsuzsanna,Tolcher Anthony W,Italiano Antoine,Cupissol Didier,López-Pousa Antonio,Chawla Sant P,Bompas Emmanuelle,Babovic Nada,Penel Nicolas,Isambert Nicolas,Staddon Arthur P,Saâda-Bouzid Esma,Santoro Armando,Franke Fabio A,Cohen Patrick,Le-Guennec Solenn,Demetri George D

Publisher

Elsevier BV

Subject

Oncology

Reference43 articles.

1. Clinicopathologic considerations: how can we fine tune our approach to sarcoma?;Demicco;Semin Oncol,2011

2. Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review;Wibmer;Ann Oncol,2010

3. Systematic therapy for unresectable or metastatic soft-tissue sarcomas: past, present, and future;Morgan;Curr Oncol Rep,2011

4. Soft tissue sarcoma, version 2.2014;von Mehren;J Natl Compr Canc Netw,2014

5. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Ann Oncol,2014

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiproliferative and Pro-Apoptotic Activity and Tubulin Dynamics Modulation of 1H-Benzimidazol-2-yl Hydrazones in Human Breast Cancer Cell Line MDA-MB-231;Molecules;2024-05-20

2. Patient-reported outcomes in randomized clinical trials of systemic therapy for advanced soft tissue sarcomas in adults: A systematic review;Critical Reviews in Oncology/Hematology;2024-05

3. 3,4-Diarylisoxazoles─Analogues of Combretastatin A-4: Design, Synthesis, and Biological Evaluation In Vitro and In Vivo;ACS Pharmacology & Translational Science;2024-01-16

4. Phase I study of ombrabulin in combination with paclitaxel and carboplatin in Japanese patients with advanced solid tumors;International Journal of Gynecologic Cancer;2023-11-20

5. Development of tubulin polymerization inhibitors as anticancer agents;Expert Opinion on Therapeutic Patents;2023-11-02